Go Pro

Envista (NVST) Competitors

Envista logo
$27.39 +0.08 (+0.29%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$27.31 -0.08 (-0.29%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NVST vs. ALGN, XRAY, BRBR, SOLV, and SNN

Should you buy Envista stock or one of its competitors? MarketBeat compares Envista with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envista include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Solventum (SOLV), and Smith & Nephew SNATS (SNN).

How does Envista compare to Align Technology?

Envista (NYSE:NVST) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

88.4% of Align Technology shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.81B1.59$47M$0.4166.80
Align Technology$4.03B3.00$410.35M$5.7529.42

In the previous week, Align Technology had 21 more articles in the media than Envista. MarketBeat recorded 32 mentions for Align Technology and 11 mentions for Envista. Envista's average media sentiment score of 1.03 beat Align Technology's score of 0.79 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
14 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market.

Align Technology has a net margin of 9.99% compared to Envista's net margin of 2.41%. Align Technology's return on equity of 15.86% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Align Technology 9.99%15.86%10.32%

Envista currently has a consensus target price of $28.62, suggesting a potential upside of 4.48%. Align Technology has a consensus target price of $206.36, suggesting a potential upside of 21.99%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Align Technology beats Envista on 14 of the 17 factors compared between the two stocks.

How does Envista compare to DENTSPLY SIRONA?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

Envista has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

In the previous week, Envista had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 11 mentions for Envista and 9 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 1.03 beat DENTSPLY SIRONA's score of 0.74 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DENTSPLY SIRONA
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.81B1.59$47M$0.4166.80
DENTSPLY SIRONA$3.68B0.73-$598M-$3.15N/A

Envista currently has a consensus price target of $28.62, indicating a potential upside of 4.48%. DENTSPLY SIRONA has a consensus price target of $13.46, indicating a potential upside of 0.68%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than DENTSPLY SIRONA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
DENTSPLY SIRONA
3 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.00

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
DENTSPLY SIRONA -17.06%18.83%5.13%

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.0% of Envista shares are owned by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Envista beats DENTSPLY SIRONA on 12 of the 16 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

Envista (NYSE:NVST) and BellRing Brands (NYSE:BRBR) are related companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, BellRing Brands has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
BellRing Brands 6.78%-44.06%19.42%

95.0% of BellRing Brands shares are owned by institutional investors. 1.0% of Envista shares are owned by company insiders. Comparatively, 1.5% of BellRing Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Envista and Envista both had 11 articles in the media. Envista's average media sentiment score of 1.03 beat BellRing Brands' score of 0.80 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BellRing Brands
5 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista presently has a consensus target price of $28.62, indicating a potential upside of 4.48%. BellRing Brands has a consensus target price of $20.97, indicating a potential upside of 69.63%. Given BellRing Brands' stronger consensus rating and higher possible upside, analysts clearly believe BellRing Brands is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
BellRing Brands
1 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.47

BellRing Brands has lower revenue, but higher earnings than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.81B1.59$47M$0.4166.80
BellRing Brands$2.33B0.62$216.20M$1.299.58

Summary

BellRing Brands beats Envista on 10 of the 16 factors compared between the two stocks.

How does Envista compare to Solventum?

Envista (NYSE:NVST) and Solventum (NYSE:SOLV) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.81B1.59$47M$0.4166.80
Solventum$8.26B1.80$1.56B$8.1610.50

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Solventum 17.33%23.51%7.63%

Envista currently has a consensus price target of $28.62, indicating a potential upside of 4.48%. Solventum has a consensus price target of $86.00, indicating a potential upside of 0.36%. Given Envista's higher probable upside, equities analysts plainly believe Envista is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Solventum
1 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.46

In the previous week, Envista and Envista both had 11 articles in the media. Envista's average media sentiment score of 1.03 beat Solventum's score of 0.78 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
5 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, Solventum has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

Summary

Solventum beats Envista on 9 of the 13 factors compared between the two stocks.

How does Envista compare to Smith & Nephew SNATS?

Envista (NYSE:NVST) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

Envista has a net margin of 2.41% compared to Smith & Nephew SNATS's net margin of 0.00%. Envista's return on equity of 7.11% beat Smith & Nephew SNATS's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Smith & Nephew SNATS N/A N/A N/A

25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Envista had 6 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 11 mentions for Envista and 5 mentions for Smith & Nephew SNATS. Envista's average media sentiment score of 1.03 beat Smith & Nephew SNATS's score of 0.68 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista currently has a consensus target price of $28.62, indicating a potential upside of 4.48%. Smith & Nephew SNATS has a consensus target price of $30.93, indicating a potential downside of 1.92%. Given Envista's stronger consensus rating and higher probable upside, equities analysts plainly believe Envista is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Smith & Nephew SNATS
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17

Smith & Nephew SNATS has higher revenue and earnings than Envista.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.81B1.59$47M$0.4166.80
Smith & Nephew SNATS$6.16B2.16$625MN/AN/A

Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

Summary

Envista beats Smith & Nephew SNATS on 9 of the 14 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$4.44B$5.58B$6.86B$23.66B
Dividend YieldN/A1.79%2.59%4.21%
P/E Ratio66.8023.12282.3031.00
Price / Sales1.5956.86561.3481.85
Price / Cash12.5832.5328.6018.73
Price / Book1.456.2910.984.76
Net Income$47M$151.15M$3.49B$1.07B
7 Day Performance2.79%1.02%-0.60%-0.34%
1 Month Performance-0.71%-3.43%-5.20%-0.53%
1 Year Performance31.80%2.35%62.01%19.19%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
2.577 of 5 stars
$27.39
+0.3%
$28.62
+4.5%
+31.8%$4.44B$2.81B66.8012,000
ALGN
Align Technology
3.5637 of 5 stars
$175.05
-1.0%
$206.07
+17.7%
+23.9%$12.66B$4.03B29.3720,290
XRAY
DENTSPLY SIRONA
3.1603 of 5 stars
$13.46
-4.2%
$13.42
-0.3%
-6.5%$2.81B$3.68BN/A14,000
BRBR
BellRing Brands
4.6362 of 5 stars
$12.15
+0.2%
$20.57
+69.3%
-77.2%$1.41B$2.32B9.42380
SOLV
Solventum
2.9753 of 5 stars
$79.22
-2.6%
$81.91
+3.4%
+19.5%$14.08B$8.33B9.7120,000

Related Companies and Tools


This page (NYSE:NVST) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners